试析初孕妇人流术前药物扩宫对人流综合征的影响

摘要目的探究初孕妇人流术前药物扩宫对人流综合征的影响。方法抽取2014年1月至2015年1月来我院进行人工流产的初孕妇女320例作为本次研究对象，以自愿选择手术将其随机分为对照组及观察组，每组初孕妇女160例，对照组术前不予以任何用药，直接做人流术，观察组术前采用米非司酮联合米索前列醇药物进行扩宫；对两组初孕妇女疼痛程度、人流综合征发生情况进行对比。结果观察组并未有人流综合征发生，对照组人流综合征发生率为10.0%，组间数据差异对比存在统计学意义(P＜0.05)。结论初孕妇人流术前应用米索前列醇联合米非司酮药物扩宫镇痛效果显著，可避免人流综合征的发生，尤其适合基层医院，可在临床积极推广使用。

• 作者: 蒲小兰
• 出处: 《医师在线》 2015年6期
• 关键词: 初孕妇 人流术 药物扩宫 人流综合征中图分类号 R2 文献标号 A 文章编号 2095-7165(2015)12-0005-02Objective To explore the effect of preoperative medicine dilatation and abortion syndrome on the abortion syndrome in pregnant women.. Methodsselected January 2014 to 2015 1 month to our hospital for artificial abortion of early pregnant women 320 cases as the research object to voluntarilychoose surgery were randomly divided into control group and observation group each group of early pregnant women (160 cases control group beforethe operation will not be any medication do operation of stream of people directly the observation group before using mifepristone and misoprostolcombined with drug dilation in the two groups at the beginning of pain for pregnant women abortion syndrome was compared. Results the observationgroup did not have the occurrence of people syndrome the control group of the incidence of the syndrome was 10% the difference between the groupsof data was statistically significant (P < 0.05). Conclusion at
• 分类: [医药卫生][临床医学]